Delivery Order SPE2DB25D3005-SPE2DB25FQJBE
- Not listed
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 21, 2025, for ORSERDU 345 mg tablets in a 30-count package. This competitively awarded, firm fixed-price delivery order carries a ceiling value of $27,841.82 with an ultimate completion date of August 11, 2025. The contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical, valued at $999,999,999.00 and...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 19, 2025, for the supply of Orserdu 345 mg tablets in quantities of 30 units. This $13,920.91 firm fixed price delivery order, which is scheduled for completion by September 10, 2025, represents a non-set-aside competitive award and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award falls under AmerisourceBergen's significant Indefinite Delivery...
- The Defense Logistics Agency awarded a $27,841.82 firm fixed price delivery order to AmerisourceBergen Drug Corp for 30-count tablets of Orserdu 345 mg, with an ultimate completion date of August 21, 2025. This non-set-aside competitive award was issued on July 31, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, has established itself as a...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 20, 2025, for ORSERDU 86 mg tablets (30-count units) valued at $9,394.44 under a firm fixed-price contract type. This non-set-aside delivery order is scheduled for completion by September 11, 2025, with performance taking place at the vendor's corporate office location in Conshohocken, Pennsylvania. The award represents a routine pharmaceutical procurement within the military...
- The Defense Logistics Agency awarded a delivery order valued at $13,920.91 to AmerisourceBergen Drug Corp for 30-count tablets of Orserdu 345 mg, with an ultimate completion date of September 10, 2025. This competitively awarded, firm fixed-price contract involves no set-aside designation and is being performed at the vendor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal healthcare vendor, is...
- The Defense Logistics Agency's Medical Supply Chain awarded a $2,881.36 delivery order to AmerisourceBergen Drug Corp on August 12, 2025, with an ultimate completion date of August 13, 2025. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded to the pharmaceutical distributor headquartered in Conshohocken, Pennsylvania. The delivery order represents a child contract executed under AmerisourceBergen's broader federal contracting relationship with the...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $37,569.10 by the Defense Logistics Agency's Medical Supply Chain on August 4, 2025. The contract is structured as a firm fixed-price delivery order with an ultimate completion date of August 5, 2025, and represents a non-competitive set-aside award. This delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, received a delivery order award on July 28, 2025, valued at $13,817.42 under a firm fixed-price contract with the Defense Logistics Agency's Medical Supply Chain. This non-set-aside, competitively awarded delivery order is part of AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated as SPE2DX, valued at $999,999,999.00 through December...
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $1,651.68 by the Defense Logistics Agency's Medical Supply Chain on August 19, 2025, with completion scheduled for August 20, 2025. This is a firm fixed price, non-set-aside delivery order issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), which is valued at $999,999,999.00 and extends through December 2026. The place of performance is AmerisourceBergen's...
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $16,062.16 by the Defense Logistics Agency's Medical Supply Chain on July 23, 2025. This firm fixed price, non-competitive delivery order represents a child award under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The place of performance is listed as Conshohocken, Pennsylvania, AmerisourceBergen's corporate...
- SPE2DB25D3005Indefinite Delivery Contract
- SPE2DB25D3005-SPE2DB25FQJBEDelivery Order
The Defense Logistics Agency awarded a $13,920.91 delivery order to AmerisourceBergen Drug Corp on August 20, 2025, for the supply of Orserdu 345 mg tablets in quantities of 30 units. This contract utilizes firm fixed price terms with no set-aside designation, indicating competitive award to this qualified pharmaceutical distributor. The place of performance is located in Conshohocken, Pennsylvania, with an ultimate completion date of September 11, 2025. This delivery order represents a relatively modest transaction within AmerisourceBergen's broader federal pharmaceutical supply portfolio. This delivery order falls under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. As a major pharmaceutical distributor and critical vendor for federal medical procurement, AmerisourceBergen serves multiple federal healthcare systems including the Defense Health Agency and U.S. Coast Guard. The company's federal contract awards consistently demonstrate capability in delivering specialized medications, brand-name and generic drugs, vaccines, and medical supplies across multiple therapeutic domains to support military healthcare programs worldwide.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $13.9k | 8/20/25 |